STROMECTOL (ivermectin) tablets , FDA-approved label PDF, NDA 050742/S-030 (label revised 03/2022) (2022)

Government Record · Merck Sharp & Dohme Corp.; U.S. Food and Drug Administration, Drugs@FDA · March 2022

Merck Sharp & Dohme Corp., 2022-03: Drugs@FDA copy of the same Stromectol label (11 pages), recording that a high-fat meal raises ivermectin bioavailability about 2.5-fold and that the drug is a CYP3A4 substrate. This is the label version the food-effect and interaction claims rest on.

Administration of 30 mg ivermectin following a high-fat meal resulted in an approximate 2.5-fold increase in bioavailability relative to administration of 30 mg ivermectin in the fasted state.

2

Merck Sharp & Dohme Corp., 2022-03: Drugs@FDA copy of the same Stromectol label (11 pages), recording that a high-fat meal raises ivermectin bioavailability about 2.5-fold and that the drug is a CYP3A4 substrate. This is the label version the food-effect and interaction claims rest on. Study type: regulatory record.